Trial Profile
Prospective study on identification of effectiveness, safety and effect predictors of benralizumab for bronchial asthma
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Apr 2018
Price :
$35
*
At a glance
- Drugs Benralizumab (Primary)
- Indications Asthma
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms J-BEST
- 18 Apr 2018 Status changed from not yet recruiting to recruiting.
- 03 Apr 2018 New trial record